GlassScriptPhysician profile
John R Hall
NPI 1639152416
$1,010.31
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $673 · 2020: $153 · 2021: $137 · 2022: $48.42.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $418.44 | 2019-2020 | |
| Boston Scientific Corporation | $266.20 | 2019 | |
| Medtronic, INC. | $139.52 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $65.07 | 2019-2020 | |
| Grt US Holding, INC. | $28.90 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.94 | 2019 | |
| Scilex Pharmaceuticals INC. | $16.84 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.67 | 2019 | |
| Abbott Laboratories | $13.93 | 2019 | |
| Pacira Therapeutics, INC. | $13.69 | 2019 | |
| Sun Pharmaceutical Industries INC. | $13.11 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.